Fig. 1From: Platelet inhibition during ticagrelor monotherapy versus ticagrelor plus aspirin in patients with coronary artery disease (TEMPLATE study): study protocol for a randomised controlled trialTrial schema. Schema showing the recruitment pathway with the number of patients to be recruited, anticipated eligibility, recruitment and follow-up rates. ASP aspirin, CLOP clopidogrel, TIC ticagrelorBack to article page